Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of a vaccine therapy for patients with recurrent B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma | Phase 1 | Status: COMPLETED